Correction to:
Molecular Psychiatry (2017) 22, 336–345; doi:10.1038/mp.2016.244;published online
17 January 2017
Data access for several cohorts used in this study was provided by the National Center
for Biotechnology Information (NCBI) database of Genotypes and Phenotypes (dbGaP).
dbGaP
accession numbers for these cohorts were as follows:
Cardiovascular Health Study (CHS): phs000287.v4.p1, phs000377.v5.p1 and
phs000226.v3.p1.
Framingham Heart Study (FHS): phs000007.v23.p8 and phs000342.v11.p8.
Multi-Site Collaborative Study for Genotype-Phenotype Associations in Alzheimer’s
Disease (GENADA): phs000219.v1.p1.
Long Life Family Study (LLFS): phs000397.v1.p1.
Genetics of Late Onset Alzheimer’s Disease Study (LOAD): phs000168.v1.p1.
Minnesota Center for Twin and Family Research (MCTFR): phs000620.v1.p1.
Philadelphia Neurodevelopmental Cohort (PNC): phs000607.v1.p1.
The acknowledgment statements for these cohorts are provided below.
Framingham Heart Study: The Framingham Heart Study is conducted and supported by the
National Heart, Lung, and Blood Institute (NHLBI) in collaboration with Boston
University (contracts N01HC25195 and HHSN268201500001I). This article was not prepared
in collaboration with investigators of the Framingham Heart Study and does not
necessarily reflect the opinions or views of the Framingham Heart Study, Boston
University, or the NHLBI. Funding for SHARe Affymetrix genotyping was provided by
NHLBI
contract N02HL64278. SHARe Illumina genotyping was provided under an agreement between
Illumina and Boston University.
Cardiovascular Health Study (CHS): this research was supported by contracts
HHSN268201200036C, HHSN268200800007C, N01HC85079, N01HC85080, N01HC85081, N01HC85082,
N01HC85083, N01HC85084, N01HC85085, N01HC85086, N01HC35129, N01HC15103, N01HC55222,
N01HC75150, N01HC45133 and N01HC85239; grants U01 HL080295 and U01 HL130014 from the
NHLBI, and R01AG023629 from the National Institute on Aging, with additional
contribution from the National Institute of Neurological Disorders and Stroke. A full
list of principal CHS investigators and institutions can be found at https://chs-nhlbi.org/pi.
This
article was not prepared in collaboration with CHS investigators and does not
necessarily reflect the opinions or views of CHS or the NHLBI. Support for the
genotyping through the CARe Study was provided by NHLBI contract N01HC65226. Support
for
the CHS Whole Genome Study was provided by NHLBI grant HL087652. Additional support
for
infrastructure was provided by HL105756, and additional genotyping among the
African-American cohort was supported in part by HL085251; DNA handling and genotyping
at Cedars-Sinai Medical Center were supported in part by National Center for Research
Resources grant UL1RR033176, now through National Center for Advancing Translational
Technologies CTSI grant UL1TR000124; in addition to National Institute of Diabetes
and
Digestive and Kidney Diseases grant DK063491 to the Southern California Diabetes
Endocrinology Research Center.
Multi-Site Collaborative Study for Genotype-Phenotype Associations in Alzheimer’s
Disease: the genotypic and associated phenotypic data used in the study were provided
by
the GlaxoSmithKline, R&D Limited. Details on data acquisition were published
previously (Li H, Wetten S, Li L, St Jean PL, Upmanyu R, Surh L et al.,
Candidate single-nucleotide polymorphisms from a genome-wide association study of
Alzheimer disease, Arch Neurol 2008; 65: 45–53 and Filippini N,
Rao A, Wetten S, Gibson RA, Borrie M, Guzman D et al., Anatomically-distinct
genetic associations of APOE epsilon4 allele load with regional cortical atrophy in
Alzheimer’s disease, Neuroimage 2009; 44: 724–728).
Genetics of Late Onset Alzheimer’s Disease Study: funding support for the Genetic
Consortium for Late Onset Alzheimer’s Disease was provided through the Division of
Neuroscience, National Institute on Aging (NIA). The consortium includes a genome-wide
association study funded as part of the Division of Neuroscience, NIA. Assistance
with
phenotype harmonization and genotype cleaning, as well as with general study
coordination, was provided by the consortium. A list of contributing investigators
is
available at https://www.ncbi.nlm.nih.gov/projects/gap/cgi-bin/study.cgi?study_id=phs000168.v1.p1.
Long Life Family Study: funding support for the Long Life Family Study was provided
by
the Division of Geriatrics and Clinical Gerontology, NIA. The study includes GWAS
analyses for factors that contribute to long and healthy life. Assistance with phenotype
harmonization and genotype cleaning as well as with general study coordination was
provided by the Division of Geriatrics and Clinical Gerontology, NIA. Support for
the
collection of data sets and samples was provided via Multicenter Cooperative Agreement
support by the Division of Geriatrics and Clinical Gerontology, NIA (UO1AG023746,
UO1023755, UO1023749, UO1023744 and UO1023712). Funding support for the genotyping,
which was performed at the Johns Hopkins University Center for Inherited Disease
Research, was provided by the NIA.
Minnesota Center for Twin and Family Research: this project was led by William G.
Iacono, PhD and Matthew K. McGue, PhD (co-principal investigators) at the University
of
Minnesota. Co-investigators from the same institution included Irene J. Elkins, Margaret
A. Keyes, Lisa N. Legrand, Stephen M. Malone, William S. Oetting, Michael B. Miller
and
Saonli Basu. Funding support for this project was provided through the National
Institute on Drug Abuse (U01DA024417). Other support for sample ascertainment and
data
collection came from grants R37DA05147, R01AA09367, R01AA11886, R01DA13240 and
R01MH66140.
Philadelphia Neurodevelopmental Cohort: support for the collection of the data sets
was
provided by grant RC2MH089983 to Raquel Gur, MD and RC2MH089924 to Hakon Hakonarson,
MD,
PhD. All subjects were recruited through the Center for Applied Genomics at The
Children’s Hospital in Philadelphia.